Leerink Partnrs Analysts Decrease Earnings Estimates for Waters Co. (NYSE:WAT)

Waters Co. (NYSE:WATFree Report) – Research analysts at Leerink Partnrs cut their Q2 2024 earnings per share estimates for Waters in a research report issued to clients and investors on Tuesday, February 6th. Leerink Partnrs analyst P. Souda now expects that the medical instruments supplier will earn $2.87 per share for the quarter, down from their prior forecast of $2.91. The consensus estimate for Waters’ current full-year earnings is $11.92 per share. Leerink Partnrs also issued estimates for Waters’ FY2024 earnings at $11.95 EPS, Q2 2025 earnings at $3.21 EPS, Q3 2025 earnings at $3.16 EPS, Q4 2025 earnings at $4.31 EPS and FY2025 earnings at $13.16 EPS.

A number of other research analysts have also weighed in on the company. Wells Fargo & Company dropped their target price on Waters from $305.00 to $285.00 and set an “equal weight” rating on the stock in a report on Wednesday, November 8th. Barclays lifted their price objective on shares of Waters from $230.00 to $275.00 and gave the stock an “underweight” rating in a report on Thursday, January 25th. Wolfe Research began coverage on shares of Waters in a report on Wednesday, December 13th. They issued a “peer perform” rating for the company. JPMorgan Chase & Co. dropped their price target on shares of Waters from $260.00 to $250.00 and set a “neutral” rating on the stock in a research report on Wednesday, November 8th. Finally, Citigroup upped their price objective on shares of Waters from $265.00 to $300.00 and gave the stock a “neutral” rating in a research report on Monday, December 11th. One research analyst has rated the stock with a sell rating and eight have given a hold rating to the company. Based on data from MarketBeat.com, Waters currently has an average rating of “Hold” and a consensus price target of $285.38.

Read Our Latest Analysis on Waters

Waters Price Performance

Shares of NYSE WAT opened at $323.54 on Thursday. The company has a debt-to-equity ratio of 2.71, a quick ratio of 1.46 and a current ratio of 0.69. The firm’s 50-day simple moving average is $313.53 and its 200 day simple moving average is $284.83. The stock has a market cap of $19.13 billion, a price-to-earnings ratio of 29.82, a PEG ratio of 7.03 and a beta of 0.92. Waters has a fifty-two week low of $231.90 and a fifty-two week high of $346.24.

Waters (NYSE:WATGet Free Report) last released its quarterly earnings data on Tuesday, February 6th. The medical instruments supplier reported $3.62 earnings per share for the quarter, beating analysts’ consensus estimates of $3.56 by $0.06. The firm had revenue of $819.50 million for the quarter, compared to analyst estimates of $815.50 million. Waters had a net margin of 21.72% and a return on equity of 81.30%. The business’s quarterly revenue was down 4.5% compared to the same quarter last year. During the same period last year, the firm earned $3.84 earnings per share.

Institutional Investors Weigh In On Waters

Several large investors have recently modified their holdings of the stock. Nuance Investments LLC grew its holdings in Waters by 356.0% during the fourth quarter. Nuance Investments LLC now owns 419,363 shares of the medical instruments supplier’s stock valued at $138,067,000 after purchasing an additional 327,389 shares during the period. Principal Financial Group Inc. lifted its position in shares of Waters by 1.4% during the 4th quarter. Principal Financial Group Inc. now owns 374,813 shares of the medical instruments supplier’s stock valued at $123,400,000 after buying an additional 5,002 shares during the last quarter. Envestnet Portfolio Solutions Inc. grew its stake in shares of Waters by 12.8% during the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 2,267 shares of the medical instruments supplier’s stock worth $746,000 after acquiring an additional 257 shares during the period. Dimensional Fund Advisors LP increased its holdings in Waters by 5.8% in the 4th quarter. Dimensional Fund Advisors LP now owns 346,812 shares of the medical instruments supplier’s stock worth $114,191,000 after acquiring an additional 18,946 shares during the last quarter. Finally, QRG Capital Management Inc. purchased a new stake in Waters in the 4th quarter worth about $217,000. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Waters Company Profile

(Get Free Report)

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

See Also

Earnings History and Estimates for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.